Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Healome Therapeutics

Healome Therapeutics

SeedUS
Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
4
Financing history
1 rounds
  1. Jul 7, 2026
    Seed Round · amount undisclosed
    Empirical Ventures (lead) via Johnathan MatlockOshen Bio (participant)DEBRA Research (participant)Cure EB (participant)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “Healome Therapeutics Closes £2 Million Seed Round Led by Empirical Ventures to Advance Eye-Drop Matrix Technology for Ocular Surface Diseases”
Investors on record
4 edges
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
  1. Jul 7, 2026
    Healome Therapeutics announced Seed Round, led by Empirical Ventures
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
1 observations
Every observation on this company